WHO grants pre-qualification status for Biological E.’s novel oral polio vaccine type 2

Hyderabad-based firm has received technology for the next-gen live, attenuated oral vaccine to combat cVDPV2 outbreaks from PT BioFarma of Indonesia, selected for Bill and Melinda Gates Foundation grant